Tizanidine Hydrochloride Capsule
Product Images NDC 72888-002

12 FDA label images from Advagen Pharma Limited · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Tizanidine Hydrochloride (NDC 72888-002). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advagen Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

"image Description" (Tizanidine Hydrochloride Capsules Structure)

"image Description" (Tizanidine Hydrochloride Capsules Structure)
Chemical structure of tizanidine hydrochloride, showing the molecular arrangement with chlorine, nitrogen, sulfur atoms, and the attached hydrochloride group.*
FDA Label Image

"image Description" (Tizanidine Hydrochloride Capsules Figure 1)

"image Description" (Tizanidine Hydrochloride Capsules Figure 1)
A pharmacokinetic profile chart showing plasma concentration (ng/mL) of tizanidine over time (hours) after dosing. Four curves represent 2 mg and 4 mg tizanidine tablets and capsules, both with and without food, mapping concentration changes up to 24 hours post-dose.*
FDA Label Image

"image Description" (Tizanidine Hydrochloride Capsules Figure 2)

"image Description" (Tizanidine Hydrochloride Capsules Figure 2)
A line graph demonstrating improvement in Ashworth Score over time post-dose in hours. It compares three groups: 16 mg tizanidine, 8 mg tizanidine, and placebo, showing score improvement from 0 to 6 hours after dosing with error bars indicating variability.*
FDA Label Image

"image Description" (Tizanidine Hydrochloride Capsules Figure 3)

"image Description" (Tizanidine Hydrochloride Capsules Figure 3)
A line chart comparing improvement in Ashworth Score over three study time points (end of titration, end of maintenance, and endpoint) between tizanidine hydrochloride (mean dose 28.8 mg) and placebo groups. The vertical axis represents improvement scores, with data points plotted and error bars shown for each group at each time point.*
FDA Label Image

"image Description" (Tizanidine Hydrochloride Capsules 2mg 150 Count)

"image Description" (Tizanidine Hydrochloride Capsules 2mg 150 Count)
Label for tizanidine hydrochloride Capsules 2 mg by Advagen Pharma Limited with a package count of 150 capsules. The label states the active ingredient strength as 2 mg (equivalent to 2.29 mg tizanidine hydrochloride USP) and notes the product is Rx only. The label includes storage instructions, distributor and manufacturer information, barcode, and a warning about non-interchangeability with Zanaflex tablets.*
FDA Label Image

Image Description (Tizanidine Hydrochloride Capsules 2mg 30 Count)

Image Description (Tizanidine Hydrochloride Capsules 2mg 30 Count)
Label for Tizanidine Hydrochloride capsules 2 mg by Advagen Pharma Limited. The label states each capsule contains 2.29 mg tizanidine hydrochloride USP (2 mg base equivalent) and includes storage instructions and child resistance warning. Distributed by Advagen Pharma Ltd., USA, and manufactured by Rubicon Research Ltd., India. Contains 30 capsules.*
FDA Label Image

"image Description" (Tizanidine Hydrochloride Capsules 4mg 150 Count)

"image Description" (Tizanidine Hydrochloride Capsules 4mg 150 Count)
Label for Tizanidine Hydrochloride Capsules 4 mg by Advagen Pharma Limited. The label indicates 150 capsules per container, with NDC 72888-002-15. It includes storage instructions, a warning to keep medication out of reach of children, and distribution details. The label also notes the product is not interchangeable with tizanidine or Zanaflex tablets and provides manufacturing information for Rubicon Research Private Limited.*
FDA Label Image

Image Description (Tizanidine Hydrochloride Capsules 4mg 30 Count)

Image Description (Tizanidine Hydrochloride Capsules 4mg 30 Count)
Label for Tizanidine Hydrochloride Capsules 4 mg by Advagen Pharma Limited. The label states each capsule contains 4.58 mg tizanidine hydrochloride USP equivalent to 4 mg base, with storage instructions, child-resistant container warning, and distributor/manufacturer details. The package contains 30 capsules.*
FDA Label Image

"image Description" (Tizanidine Hydrochloride Capsules 6mg 150 Count)

"image Description" (Tizanidine Hydrochloride Capsules 6mg 150 Count)
Label for tizanidine hydrochloride 6 mg capsules, distributed by Advagen Pharma Limited and manufactured by Rubicon Research Private Limited. The label indicates each capsule contains 6.87 mg tizanidine hydrochloride, equivalent to 6 mg tizanidine base, and the package contains 150 capsules. It includes storage instructions, a child-resistant closure warning, a barcode, and a note that this product is not interchangeable with tizanidine tablets or Zanaflex tablets.*
FDA Label Image

Image Description (Tizanidine Hydrochloride Capsules 6mg 30 Count)

Image Description (Tizanidine Hydrochloride Capsules 6mg 30 Count)
Label for Tizanidine Hydrochloride Capsules 6 mg by Advagen Pharma Limited. The label states each capsule contains 6 mg tizanidine base equivalent from 6.87 mg tizanidine hydrochloride USP. The package contains 30 capsules. Distributed by Advagen Pharma Ltd., USA, and manufactured by Rubicon Research Ltd., India. Includes storage instructions, child-resistant closure warning, and a caution that these capsules are not interchangeable with tizanidine tablets or Zanaflex tablets.*
FDA Label Image

"image Description" (Tizanidine Hydrochloride Capsules 8mg 150 Count)

"image Description" (Tizanidine Hydrochloride Capsules 8mg 150 Count)
Label for Tizanidine Hydrochloride Capsules 8 mg, supplied by Advagen Pharma Limited. The label includes storage instructions, a caution to keep the medication out of reach of children, a warning that the capsules are not interchangeable with certain other tablets, and manufacturer details for Rubicon Research Ltd. The package contains 150 capsules and is marked Rx Only. A barcode is also present.*
FDA Label Image

Image Description (Tizanidine Hydrochloride Capsules 8mg 60 Count)

Image Description (Tizanidine Hydrochloride Capsules 8mg 60 Count)
Label for Tizanidine Hydrochloride Capsules 8 mg, containing 60 capsules. The label states each capsule contains 9.16 mg tizanidine hydrochloride, USP equivalent to 8 mg tizanidine base. Distributed by Advagen Pharma Ltd., East Windsor, NJ, USA, and manufactured by Rubicon Research Ltd., Thane, India. Includes storage instructions and child-resistant warning.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.